{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:32:35Z","timestamp":1785717155425,"version":"3.56.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1038\/s41584-024-01178-6","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:08:39Z","timestamp":1730300919000},"page":"783-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Rheumatic diseases and metabolism: where centre and periphery meet"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7823-1648","authenticated-orcid":false,"given":"Miguel","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-1328","authenticated-orcid":false,"given":"Oreste","family":"Gualillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"1178_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","volume":"84","author":"J Nicolau","year":"2017","unstructured":"Nicolau, J., Lequerre, T., Bacquet, H. & Vittecoq, O. Rheumatoid arthritis, insulin resistance, and diabetes. Joint Bone Spine 84, 411\u2013416 (2017).","journal-title":"Joint Bone Spine"},{"key":"1178_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/ar3885","volume":"14","author":"CM Spies","year":"2012","unstructured":"Spies, C. M., Straub, R. H. & Buttgereit, F. Energy metabolism and rheumatic diseases: from cell to organism. Arthritis Res. Ther. 14, 216 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"1178_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41584-021-00713-z","volume":"18","author":"V Francisco","year":"2022","unstructured":"Francisco, V. et al. A new immunometabolic perspective of intervertebral disc degeneration. Nat. Rev. Rheumatol. 18, 47\u201360 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrrheum.2017.50","volume":"13","author":"A Mobasheri","year":"2017","unstructured":"Mobasheri, A. et al. The role of metabolism in the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 13, 302\u2013311 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","volume":"13","author":"V Abella","year":"2017","unstructured":"Abella, V. et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat. Rev. Rheumatol. 13, 100\u2013109 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrrheum.2015.158","volume":"12","author":"Z Huang","year":"2016","unstructured":"Huang, Z. & Kraus, V. B. Does lipopolysaccharide-mediated inflammation have a role in OA? Nat. Rev. Rheumatol. 12, 123\u2013129 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrendo.2015.189","volume":"12","author":"DE Lackey","year":"2016","unstructured":"Lackey, D. E. & Olefsky, J. M. Regulation of metabolism by the innate immune system. Nat. Rev. Endocrinol. 12, 15\u201328 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1178_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrrheum.2014.121","volume":"10","author":"G Kerekes","year":"2014","unstructured":"Kerekes, G. et al. Rheumatoid arthritis and metabolic syndrome. Nat. Rev. Rheumatol. 10, 691\u2013696 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrrheum.2012.135","volume":"8","author":"Q Zhuo","year":"2012","unstructured":"Zhuo, Q., Yang, W., Chen, J. & Wang, Y. Metabolic syndrome meets osteoarthritis. Nat. Rev. Rheumatol. 8, 729\u2013737 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"Suppl. 2","key":"1178_CR10","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/ar4688","volume":"16","author":"RH Straub","year":"2014","unstructured":"Straub, R. H. Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases. Arthritis Res. Ther. 16 (Suppl. 2), S4 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"1178_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrendo.2016.67","volume":"12","author":"M Lopez","year":"2016","unstructured":"Lopez, M., Nogueiras, R., Tena-Sempere, M. & Dieguez, C. Hypothalamic AMPK: a canonical regulator of whole-body energy balance. Nat. Rev. Endocrinol. 12, 421\u2013432 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1178_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1210\/endrev\/bnab025","volume":"43","author":"A Jais","year":"2022","unstructured":"Jais, A. & Bruning, J. C. Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus. Endocr. Rev. 43, 314\u2013328 (2022).","journal-title":"Endocr. Rev."},{"key":"1178_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s42255-021-00345-3","volume":"3","author":"C Quarta","year":"2021","unstructured":"Quarta, C. et al. POMC neuronal heterogeneity in energy balance and beyond: an integrated view. Nat. Metab. 3, 299\u2013308 (2021).","journal-title":"Nat. Metab."},{"key":"1178_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.tips.2022.04.007","volume":"43","author":"M Lopez","year":"2022","unstructured":"Lopez, M. Hypothalamic AMPK as a possible target for energy balance-related diseases. Trends Pharmacol. Sci. 43, 546\u2013556 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"1178_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.yfrne.2009.07.001","volume":"31","author":"M Lopez","year":"2010","unstructured":"Lopez, M., Tena-Sempere, M. & Dieguez, C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front. Neuroendocrinol. 31, 113\u2013127 (2010).","journal-title":"Front. Neuroendocrinol."},{"key":"1178_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","volume":"23","author":"RJF Loos","year":"2022","unstructured":"Loos, R. J. F. & Yeo, G. S. H. The genetics of obesity: from discovery to biology. Nat. Rev. Genet. 23, 120\u2013133 (2022).","journal-title":"Nat. Rev. Genet."},{"key":"1178_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","volume":"21","author":"TD Muller","year":"2022","unstructured":"Muller, T. D., Bluher, M., Tschop, M. H. & DiMarchi, R. D. Anti-obesity drug discovery: advances and challenges. Nat. Rev. Drug. Discov. 21, 201\u2013223 (2022).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"1178_CR18","doi-asserted-by":"publisher","first-page":"eabl7398","DOI":"10.1126\/science.abl7398","volume":"381","author":"JC Bruning","year":"2023","unstructured":"Bruning, J. C. & Fenselau, H. Integrative neurocircuits that control metabolism and food intake. Science 381, eabl7398 (2023).","journal-title":"Science"},{"key":"1178_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0889-857X(21)00853-X","volume":"13","author":"JD Levine","year":"1987","unstructured":"Levine, J. D., Goetzl, E. J. & Basbaum, A. I. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. Rheum. Dis. Clin. North. Am. 13, 369\u2013383 (1987).","journal-title":"Rheum. Dis. Clin. North. Am."},{"key":"1178_CR20","first-page":"406","volume":"12","author":"JD Levine","year":"1985","unstructured":"Levine, J. D., Collier, D. H., Basbaum, A. I., Moskowitz, M. A. & Helms, C. A. Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J. Rheumatol. 12, 406\u2013411 (1985).","journal-title":"J. Rheumatol."},{"key":"1178_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/art.41950","volume":"74","author":"P Seoane-Collazo","year":"2022","unstructured":"Seoane-Collazo, P. et al. Activation of hypothalamic AMP-activated protein kinase ameliorates metabolic complications of experimental arthritis. Arthritis Rheumatol. 74, 212\u2013222 (2022).","journal-title":"Arthritis Rheumatol."},{"key":"1178_CR22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.5694\/j.1326-5377.1951.tb88497.x","volume":"1","author":"M Kelly","year":"1951","unstructured":"Kelly, M. The neurogenic factor in rheumatic inflammation. Med. J. Aust. 1, 859\u2013864 (1951).","journal-title":"Med. J. Aust."},{"key":"1178_CR23","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00109-007-0277-z","volume":"85","author":"CT Taylor","year":"2007","unstructured":"Taylor, C. T. & Colgan, S. P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295\u20131300 (2007).","journal-title":"J. Mol. Med."},{"key":"1178_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/jlb.66.6.889","volume":"66","author":"JS Lewis","year":"1999","unstructured":"Lewis, J. S., Lee, J. A., Underwood, J. C., Harris, A. L. & Lewis, C. E. Macrophage responses to hypoxia: relevance to disease mechanisms. J. Leukoc. Biol. 66, 889\u2013900 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"1178_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cellimm.2018.04.014","volume":"330","author":"RM Pirzgalska","year":"2018","unstructured":"Pirzgalska, R. M. & Domingos, A. I. Macrophages in obesity. Cell. Immunol. 330, 183\u2013187 (2018).","journal-title":"Cell. Immunol."},{"key":"1178_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.metabol.2014.10.014","volume":"64","author":"C Procaccini","year":"2015","unstructured":"Procaccini, C., Pucino, V., Mantzoros, C. S. & Matarese, G. Leptin in autoimmune diseases. Metabolism 64, 92\u2013104 (2015).","journal-title":"Metabolism"},{"key":"1178_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cyto.2016.10.011","volume":"98","author":"A La Cava","year":"2017","unstructured":"La Cava, A. Leptin in inflammation and autoimmunity. Cytokine 98, 51\u201358 (2017).","journal-title":"Cytokine"},{"key":"1178_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-319-48382-5_7","volume":"960","author":"S Carobbio","year":"2017","unstructured":"Carobbio, S., Pellegrinelli, V. & Vidal-Puig, A. Adipose tissue function and expandability as determinants of lipotoxicity and the metabolic syndrome. Adv. Exp. Med. Biol. 960, 161\u2013196 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1178_CR29","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/bph.14181","volume":"175","author":"V Francisco","year":"2018","unstructured":"Francisco, V. et al. Adipokines and inflammation: is it a question of weight? Br. J. Pharmacol. 175, 1569\u20131579 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"1178_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm, T. V., Meier, D. T., Olefsky, J. M. & Donath, M. Y. Inflammation in obesity, diabetes, and related disorders. Immunity 55, 31\u201355 (2022).","journal-title":"Immunity"},{"key":"1178_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41574-019-0283-6","volume":"16","author":"CM Larabee","year":"2020","unstructured":"Larabee, C. M., Neely, O. C. & Domingos, A. I. Obesity: a neuroimmunometabolic perspective. Nat. Rev. Endocrinol. 16, 30\u201343 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1178_CR32","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1016\/j.neuron.2022.10.017","volume":"110","author":"N Martinez-Sanchez","year":"2022","unstructured":"Martinez-Sanchez, N. et al. The sympathetic nervous system in the 21st century: neuroimmune interactions in metabolic homeostasis and obesity. Neuron 110, 3597\u20133626 (2022).","journal-title":"Neuron"},{"key":"1178_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1146\/annurev-cellbio-120319-114106","volume":"37","author":"CJO O\u2019Brien","year":"2021","unstructured":"O\u2019Brien, C. J. O., Haberman, E. R. & Domingos, A. I. A tale of three systems: toward a neuroimmunoendocrine model of obesity. Annu. Rev. Cell Dev. Biol. 37, 549\u2013573 (2021).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1178_CR34","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrrheum.2017.172","volume":"13","author":"RH Straub","year":"2017","unstructured":"Straub, R. H. The brain and immune system prompt energy shortage in chronic inflammation and ageing. Nat. Rev. Rheumatol. 13, 743\u2013751 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR35","doi-asserted-by":"publisher","first-page":"107219","DOI":"10.1016\/j.phrs.2024.107219","volume":"205","author":"Y Farrag","year":"2024","unstructured":"Farrag, Y. et al. Adipokines as potential pharmacological targets for immune inflammatory rheumatic diseases: focus on rheumatoid arthritis, osteoarthritis, and intervertebral disc degeneration. Pharmacol. Res. 205, 107219 (2024).","journal-title":"Pharmacol. Res."},{"key":"1178_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrrheum.2011.107","volume":"7","author":"R Gomez","year":"2011","unstructured":"Gomez, R. et al. What\u2019s new in our understanding of the role of adipokines in rheumatic diseases? Nat. Rev. Rheumatol. 7, 528\u2013536 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/s10165-007-0628-1","volume":"17","author":"A Arshad","year":"2007","unstructured":"Arshad, A., Rashid, R. & Benjamin, K. The effect of disease activity on fat-free mass and resting energy expenditure in patients with rheumatoid arthritis versus noninflammatory arthropathies\/soft tissue rheumatism. Mod. Rheumatol. 17, 470\u2013475 (2007).","journal-title":"Mod. Rheumatol."},{"key":"1178_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bcp.2019.03.030","volume":"165","author":"V Francisco","year":"2019","unstructured":"Francisco, V. et al. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem. Pharmacol. 165, 196\u2013206 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"1178_CR39","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41366-019-0505-y","volume":"44","author":"SH Chin","year":"2020","unstructured":"Chin, S. H., Huang, W. L., Akter, S. & Binks, M. Obesity and pain: a systematic review. Int. J. Obes. 44, 969\u2013979 (2020).","journal-title":"Int. J. Obes."},{"key":"1178_CR40","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1210\/endrev\/bnab034","volume":"43","author":"AM Angelidi","year":"2022","unstructured":"Angelidi, A. M., Belanger, M. J., Kokkinos, A., Koliaki, C. C. & Mantzoros, C. S. Novel noninvasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy. Endocr. Rev. 43, 507\u2013557 (2022).","journal-title":"Endocr. Rev."},{"key":"1178_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neuroscience.2020.04.034","volume":"437","author":"NRV Dragano","year":"2020","unstructured":"Dragano, N. R. V., Ferno, J., Dieguez, C., Lopez, M. & Milbank, E. Recent updates on obesity treatments: available drugs and future directions. Neuroscience 437, 215\u2013239 (2020).","journal-title":"Neuroscience"},{"key":"1178_CR42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pr.117.014803","volume":"70","author":"TD M\u00fcller","year":"2018","unstructured":"M\u00fcller, T. D. et al. Anti-obesity therapy: from rainbow pills to polyagonists. Pharmacol. Rev. 70, 712\u2013746 (2018).","journal-title":"Pharmacol. Rev."},{"key":"1178_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170361","volume":"12","author":"J Hallajzadeh","year":"2017","unstructured":"Hallajzadeh, J. et al. Metabolic syndrome and its components among rheumatoid arthritis patients: a comprehensive updated systematic review and meta-analysis. PLoS ONE 12, e0170361 (2017).","journal-title":"PLoS ONE"},{"key":"1178_CR44","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/acr.21627","volume":"64","author":"F Wolfe","year":"2012","unstructured":"Wolfe, F. & Michaud, K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res. 64, 1471\u20131479 (2012).","journal-title":"Arthritis Care Res."},{"key":"1178_CR45","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2014.732","volume":"311","author":"CL Ogden","year":"2014","unstructured":"Ogden, C. L., Carroll, M. D., Kit, B. K. & Flegal, K. M. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 311, 806\u2013814 (2014).","journal-title":"JAMA"},{"key":"1178_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrrheum.2015.93","volume":"11","author":"N Sattar","year":"2015","unstructured":"Sattar, N. & McInnes, I. B. Rheumatoid arthritis: debunking the obesity-mortality paradox in RA. Nat. Rev. Rheumatol. 11, 445\u2013446 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR47","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/art.39136","volume":"67","author":"JF Baker","year":"2015","unstructured":"Baker, J. F. et al. Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. Arthritis Rheumatol. 67, 1711\u20131717 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1178_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11926-015-0550-z","volume":"18","author":"MD George","year":"2016","unstructured":"George, M. D. & Baker, J. F. The obesity epidemic and consequences for rheumatoid arthritis care. Curr. Rheumatol. Rep. 18, 6 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1178_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13075-016-1146-3","volume":"18","author":"L Mangnus","year":"2016","unstructured":"Mangnus, L. et al. Body mass index and extent of MRI-detected inflammation: opposite effects in rheumatoid arthritis versus other arthritides and asymptomatic persons. Arthritis Res. Ther. 18, 245 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"1178_CR50","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/acr.23579","volume":"70","author":"JF Baker","year":"2018","unstructured":"Baker, J. F. et al. Obesity, weight loss, and progression of disability in rheumatoid arthritis. Arthritis Care Res. 70, 1740\u20131747 (2018).","journal-title":"Arthritis Care Res."},{"key":"1178_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cytogfr.2007.04.007","volume":"18","author":"F Lago","year":"2007","unstructured":"Lago, F., Dieguez, C., Gomez-Reino, J. & Gualillo, O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor. Rev. 18, 313\u2013325 (2007).","journal-title":"Cytokine Growth Factor. Rev."},{"key":"1178_CR52","doi-asserted-by":"publisher","first-page":"103352","DOI":"10.1016\/j.drudis.2022.103352","volume":"27","author":"M Gonzalez-Rodriguez","year":"2022","unstructured":"Gonzalez-Rodriguez, M. et al. Adipokines as targets in musculoskeletal immune and inflammatory diseases. Drug. Discov. Today 27, 103352 (2022).","journal-title":"Drug. Discov. Today"},{"key":"1178_CR53","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2022.04.010","volume":"34","author":"G Karsenty","year":"2022","unstructured":"Karsenty, G. & Khosla, S. The crosstalk between bone remodeling and energy metabolism: a translational perspective. Cell Metab. 34, 805\u2013817 (2022).","journal-title":"Cell Metab."},{"key":"1178_CR54","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/2211-5463.12326","volume":"7","author":"X Sun","year":"2017","unstructured":"Sun, X. et al. Leptin-induced migration and angiogenesis in rheumatoid arthritis is mediated by reactive oxygen species. FEBS Open. Bio 7, 1899\u20131908 (2017).","journal-title":"FEBS Open. Bio"},{"key":"1178_CR55","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191593","volume":"218","author":"P de Candia","year":"2021","unstructured":"de Candia, P. et al. The pleiotropic roles of leptin in metabolism, immunity, and cancer. J. Exp. Med. 218, e20191593 (2021).","journal-title":"J. Exp. Med."},{"key":"1178_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/annrheumdis-2013-204189","volume":"73","author":"J Conde","year":"2014","unstructured":"Conde, J. et al. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals. Ann. Rheum. Dis. 73, 631\u2013633 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1178_CR57","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jor.23377","volume":"35","author":"M Scotece","year":"2017","unstructured":"Scotece, M. et al. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient. J. Orthop. Res. 35, 1299\u20131303 (2017).","journal-title":"J. Orthop. Res."},{"key":"1178_CR58","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3389\/fphys.2018.00640","volume":"9","author":"V Francisco","year":"2018","unstructured":"Francisco, V. et al. Obesity, fat mass and immune system: role for leptin. Front. Physiol. 9, 640 (2018).","journal-title":"Front. Physiol."},{"key":"1178_CR59","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3389\/fimmu.2018.02509","volume":"9","author":"Q Wang","year":"2018","unstructured":"Wang, Q. & Wu, H. T cells in adipose tissue: critical players in immunometabolism. Front. Immunol. 9, 2509 (2018).","journal-title":"Front. Immunol."},{"key":"1178_CR60","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrendo.2015.48","volume":"11","author":"S Kalin","year":"2015","unstructured":"Kalin, S. et al. Hypothalamic innate immune reaction in obesity. Nat. Rev. Endocrinol. 11, 339\u2013351 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1178_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1172\/JCI88878","volume":"127","author":"A Jais","year":"2017","unstructured":"Jais, A. & Bruning, J. C. Hypothalamic inflammation in obesity and metabolic disease. J. Clin. Invest. 127, 24\u201332 (2017).","journal-title":"J. Clin. Invest."},{"key":"1178_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neuroscience.2019.10.012","volume":"447","author":"NR Dragano","year":"2020","unstructured":"Dragano, N. R., Monfort-Pires, M. & Velloso, L. A. Mechanisms mediating the actions of fatty acids in the hypothalamus. Neuroscience 447, 15\u201327 (2020).","journal-title":"Neuroscience"},{"key":"1178_CR63","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/rheumatology\/keh055","volume":"43","author":"M Otero","year":"2004","unstructured":"Otero, M. et al. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology 43, 306\u2013310 (2004).","journal-title":"Rheumatology"},{"key":"1178_CR64","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10753-008-9082-2","volume":"31","author":"SS Koca","year":"2008","unstructured":"Koca, S. S. et al. Ghrelin and obestatin levels in rheumatoid arthritis. Inflammation 31, 329\u2013335 (2008).","journal-title":"Inflammation"},{"key":"1178_CR65","doi-asserted-by":"publisher","first-page":"343746","DOI":"10.1155\/2014\/343746","volume":"2014","author":"V Abella","year":"2014","unstructured":"Abella, V. et al. Adipokines, metabolic syndrome and rheumatic diseases. J. Immunol. Res. 2014, 343746 (2014).","journal-title":"J. Immunol. Res."},{"key":"1178_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1159\/000228912","volume":"16","author":"A Stofkova","year":"2009","unstructured":"Stofkova, A. et al. Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritis-induced anorexia in Lewis rats. Neuroimmunomodulation 16, 377\u2013384 (2009).","journal-title":"Neuroimmunomodulation"},{"key":"1178_CR67","doi-asserted-by":"publisher","first-page":"R877","DOI":"10.1152\/ajpregu.00447.2012","volume":"304","author":"AB Gomez-SanMiguel","year":"2013","unstructured":"Gomez-SanMiguel, A. B. et al. Systemic \u03b1-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R877\u2013R886 (2013).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1178_CR68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/ijms19020367","volume":"19","author":"S Grassel","year":"2018","unstructured":"Grassel, S. & Muschter, D. Do neuroendocrine peptides and their receptors qualify as novel therapeutic targets in osteoarthritis? Int. J. Mol. Sci. 19, 367 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1178_CR69","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1210\/er.2011-1016","volume":"33","author":"M Bohm","year":"2012","unstructured":"Bohm, M. & Grassel, S. Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research. Endocr. Rev. 33, 623\u2013651 (2012).","journal-title":"Endocr. Rev."},{"key":"1178_CR70","doi-asserted-by":"publisher","first-page":"8158","DOI":"10.3390\/ijms23158158","volume":"23","author":"D Gao","year":"2022","unstructured":"Gao, D., Gao, X., Yang, F. & Wang, Q. Neuroimmune crosstalk in rheumatoid arthritis. Int. J. Mol. Sci. 23, 8158 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1178_CR71","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1749-6632.2000.tb05448.x","volume":"917","author":"IC Chikanza","year":"2000","unstructured":"Chikanza, I. C., Petrou, P. & Chrousos, G. Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiologic implications. Ann. N. Y. Acad. Sci. 917, 825\u2013834 (2000).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1178_CR72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03345073","volume":"25","author":"M Cutolo","year":"2002","unstructured":"Cutolo, M., Foppiani, L. & Minuto, F. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J. Endocrinol. Invest. 25, 19\u201323 (2002).","journal-title":"J. Endocrinol. Invest."},{"key":"1178_CR73","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-020-2235-7","volume":"581","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Brain control of humoral immune responses amenable to behavioural modulation. Nature 581, 204\u2013208 (2020).","journal-title":"Nature"},{"key":"1178_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fendo.2020.00043","volume":"11","author":"H Nishimura","year":"2020","unstructured":"Nishimura, H. et al. Acute mono-arthritis activates the neurohypophysial system and hypothalamo-pituitary adrenal axis in rats. Front. Endocrinol. 11, 43 (2020).","journal-title":"Front. Endocrinol."},{"key":"1178_CR75","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1749-6632.2009.05366.x","volume":"1193","author":"F Atzeni","year":"2010","unstructured":"Atzeni, F., Straub, R. H., Cutolo, M. & Sarzi-Puttini, P. Anti-TNF therapy restores the hypothalamic-pituitary-adrenal axis. Ann. N. Y. Acad. Sci. 1193, 179\u2013181 (2010).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1178_CR76","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.semarthrit.2013.04.008","volume":"43","author":"RH Straub","year":"2013","unstructured":"Straub, R. H., Bijlsma, J. W., Masi, A. & Cutolo, M. Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases \u2013 the 10-year update. Semin. Arthritis Rheum. 43, 392\u2013404 (2013).","journal-title":"Semin. Arthritis Rheum."},{"key":"1178_CR77","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","volume":"17","author":"R Seror","year":"2021","unstructured":"Seror, R., Nocturne, G. & Mariette, X. Current and future therapies for primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 17, 475\u2013486 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR78","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/nrrheum.2016.208","volume":"13","author":"A Vissink","year":"2016","unstructured":"Vissink, A. & Bootsma, H. Connective tissue diseases: refining the classification criteria for primary Sj\u00f6gren syndrome. Nat. Rev. Rheumatol. 13, 10\u201312 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1196\/annals.1366.018","volume":"1088","author":"EO Johnson","year":"2006","unstructured":"Johnson, E. O., Kostandi, M. & Moutsopoulos, H. M. Hypothalamic-pituitary-adrenal axis function in Sj\u00f6gren\u2019s syndrome: mechanisms of neuroendocrine and immune system homeostasis. Ann. N. Y. Acad. Sci. 1088, 41\u201351 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1178_CR80","first-page":"1508","volume":"25","author":"EO Johnson","year":"1998","unstructured":"Johnson, E. O., Vlachoyiannopoulos, P. G., Skopouli, F. N., Tzioufas, A. G. & Moutsopoulos, H. M. Hypofunction of the stress axis in Sj\u00f6gren\u2019s syndrome. J. Rheumatol. 25, 1508\u20131514 (1998).","journal-title":"J. Rheumatol."},{"key":"1178_CR81","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/JCI59660","volume":"122","author":"JP Thaler","year":"2012","unstructured":"Thaler, J. P. et al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 122, 153\u2013162 (2012).","journal-title":"J. Clin. Invest."},{"key":"1178_CR82","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10067-010-1573-5","volume":"30","author":"K Toth","year":"2011","unstructured":"Toth, K. et al. Synovial fluid \u03b2-endorphin level in avascular necrosis, rheumatoid arthritis, and osteoarthritis of the femoral head and knee. A controlled pilot study. Clin. Rheumatol. 30, 537\u2013540 (2011).","journal-title":"Clin. Rheumatol."},{"key":"1178_CR83","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000097183","volume":"1","author":"A Catania","year":"1994","unstructured":"Catania, A. et al. The anticytokine neuropeptide \u03b1-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation 1, 321\u2013328 (1994).","journal-title":"Neuroimmunomodulation"},{"key":"1178_CR84","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/art.1780330613","volume":"33","author":"A Bjurholm","year":"1990","unstructured":"Bjurholm, A., Kreicbergs, A., Ahmed, M. & Schultzberg, M. Noradrenergic and peptidergic nerves in the synovial membrane of the Sprague-Dawley rat. Arthritis Rheum. 33, 859\u2013865 (1990).","journal-title":"Arthritis Rheum."},{"key":"1178_CR85","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3109\/03009749109096808","volume":"20","author":"J Larsson","year":"1991","unstructured":"Larsson, J., Ekblom, A., Henriksson, K., Lundeberg, T. & Theodorsson, E. Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand. J. Rheumatol. 20, 326\u2013335 (1991).","journal-title":"Scand. J. Rheumatol."},{"key":"1178_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-8-50","volume":"8","author":"J Ferreira-Gomes","year":"2012","unstructured":"Ferreira-Gomes, J., Adaes, S., Sousa, R. M., Mendonca, M. & Castro-Lopes, J. M. Dose-dependent expression of neuronal injury markers during experimental osteoarthritis induced by monoiodoacetate in the rat. Mol. Pain. 8, 50 (2012).","journal-title":"Mol. Pain."},{"key":"1178_CR87","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/art.23403","volume":"58","author":"Y Juarranz","year":"2008","unstructured":"Juarranz, Y. et al. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Arthritis Rheum. 58, 1086\u20131095 (2008).","journal-title":"Arthritis Rheum."},{"key":"1178_CR88","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1002\/art.24846","volume":"60","author":"S Grassel","year":"2009","unstructured":"Grassel, S. et al. The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of \u03b1-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. Arthritis Rheum. 60, 3017\u20133027 (2009).","journal-title":"Arthritis Rheum."},{"key":"1178_CR89","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/87887","volume":"7","author":"M Delgado","year":"2001","unstructured":"Delgado, M., Abad, C., Martinez, C., Leceta, J. & Gomariz, R. P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7, 563\u2013568 (2001).","journal-title":"Nat. Med."},{"key":"1178_CR90","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-4419-6354-3_8","volume":"681","author":"T Brzoska","year":"2010","unstructured":"Brzoska, T., Bohm, M., Lugering, A., Loser, K. & Luger, T. A. Terminal signal: anti-inflammatory effects of \u03b1-melanocyte-stimulating hormone related peptides beyond the pharmacophore. Adv. Exp. Med. Biol. 681, 107\u2013116 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"1178_CR91","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3389\/fendo.2019.00683","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang, W., Guo, D. Y., Lin, Y. J. & Tao, Y. X. Melanocortin regulation of inflammation. Front. Endocrinol. 10, 683 (2019).","journal-title":"Front. Endocrinol."},{"key":"1178_CR92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.peptides.2015.02.001","volume":"66","author":"T Juhasz","year":"2015","unstructured":"Juhasz, T., Helgadottir, S. L., Tamas, A., Reglodi, D. & Zakany, R. PACAP and VIP signaling in chondrogenesis and osteogenesis. Peptides 66, 51\u201357 (2015).","journal-title":"Peptides"},{"key":"1178_CR93","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.4049\/jimmunol.151.3.1587","volume":"151","author":"LJ Crofford","year":"1993","unstructured":"Crofford, L. J. et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunol. 151, 1587\u20131596 (1993).","journal-title":"J. Immunol."},{"key":"1178_CR94","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/s101650200036","volume":"12","author":"S Miyazaki","year":"2002","unstructured":"Miyazaki, S. et al. ACTH expression in synovium of patients with rheumatoid arthritis and Lewis rats with adjuvant arthritis. Mod. Rheumatol. 12, 206\u2013212 (2002).","journal-title":"Mod. Rheumatol."},{"key":"1178_CR95","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/art.10526","volume":"46","author":"SJ Getting","year":"2002","unstructured":"Getting, S. J., Christian, H. C., Flower, R. J. & Perretti, M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum. 46, 2765\u20132775 (2002).","journal-title":"Arthritis Rheum."},{"key":"1178_CR96","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3389\/fendo.2019.00830","volume":"10","author":"E Milbank","year":"2019","unstructured":"Milbank, E. & Lopez, M. Orexins\/hypocretins: key regulators of energy homeostasis. Front. Endocrinol. 10, 830 (2019).","journal-title":"Front. Endocrinol."},{"key":"1178_CR97","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.biopha.2018.07.159","volume":"107","author":"M Sun","year":"2018","unstructured":"Sun, M., Wang, W., Li, Q., Yuan, T. & Weng, W. Orexin A may suppress inflammatory response in fibroblast-like synoviocytes. Biomed. Pharmacother. 107, 763\u2013768 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"1178_CR98","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12020-015-0658-y","volume":"50","author":"P Seoane-Collazo","year":"2015","unstructured":"Seoane-Collazo, P. et al. Hypothalamic-autonomic control of energy homeostasis. Endocrine 50, 276\u2013291 (2015).","journal-title":"Endocrine"},{"key":"1178_CR99","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molmet.2013.03.004","volume":"2","author":"SM Harlan","year":"2013","unstructured":"Harlan, S. M. & Rahmouni, K. PI3K signaling: a key pathway in the control of sympathetic traffic and arterial pressure by leptin. Mol. Metab. 2, 69\u201373 (2013).","journal-title":"Mol. Metab."},{"key":"1178_CR100","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrrheum.2012.181","volume":"9","author":"G Pongratz","year":"2013","unstructured":"Pongratz, G. & Straub, R. H. Role of peripheral nerve fibres in acute and chronic inflammation in arthritis. Nat. Rev. Rheumatol. 9, 117\u2013126 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR101","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-018-0062-1","volume":"15","author":"TMZ Waise","year":"2018","unstructured":"Waise, T. M. Z., Dranse, H. J. & Lam, T. K. T. The metabolic role of vagal afferent innervation. Nat. Rev. Gastroenterol. Hepatol. 15, 625\u2013636 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1178_CR102","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41569-020-00466-4","volume":"18","author":"S Padmanabhan","year":"2021","unstructured":"Padmanabhan, S. & Dominiczak, A. F. Genomics of hypertension: the road to precision medicine. Nat. Rev. Cardiol. 18, 235\u2013250 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"1178_CR103","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrneurol.2014.88","volume":"10","author":"EE Benarroch","year":"2014","unstructured":"Benarroch, E. E. The clinical approach to autonomic failure in neurological disorders. Nat. Rev. Neurol. 10, 396\u2013407 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"1178_CR104","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.aah5454","volume":"354","author":"I Espinosa-Medina","year":"2016","unstructured":"Espinosa-Medina, I. et al. The sacral autonomic outflow is sympathetic. Science 354, 893\u2013897 (2016).","journal-title":"Science"},{"key":"1178_CR105","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10286-017-0478-7","volume":"28","author":"I Espinosa-Medina","year":"2018","unstructured":"Espinosa-Medina, I., Saha, O., Boismoreau, F. & Brunet, J. F. The \u201csacral parasympathetic\u201d: ontogeny and anatomy of a myth. Clin. Auton. Res. 28, 13\u201321 (2018).","journal-title":"Clin. Auton. Res."},{"key":"1178_CR106","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10286-018-0510-6","volume":"28","author":"JP Horn","year":"2018","unstructured":"Horn, J. P. The sacral autonomic outflow is parasympathetic: Langley got it right. Clin. Auton. Res. 28, 181\u2013185 (2018).","journal-title":"Clin. Auton. Res."},{"key":"1178_CR107","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.91576.3","volume":"12","author":"M Sivori","year":"2024","unstructured":"Sivori, M. et al. The pelvic organs receive no parasympathetic innervation. eLife 12, e91576 (2024).","journal-title":"eLife"},{"key":"1178_CR108","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.brainresbull.2019.09.003","volume":"153","author":"YY Huang","year":"2019","unstructured":"Huang, Y. Y. et al. Neuroimmune crosstalk in central nervous system injury-induced infection and pharmacological intervention. Brain Res. Bull. 153, 232\u2013238 (2019).","journal-title":"Brain Res. Bull."},{"key":"1178_CR109","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/art.20987","volume":"52","author":"P Harle","year":"2005","unstructured":"Harle, P., Mobius, D., Carr, D. J., Scholmerich, J. & Straub, R. H. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum. 52, 1305\u20131313 (2005).","journal-title":"Arthritis Rheum."},{"key":"1178_CR110","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/ard.16.4.471","volume":"16","author":"FD Hart","year":"1957","unstructured":"Hart, F. D., Golding, J. R. & Mackenzie, D. H. Neuropathy in rheumatoid disease. Ann. Rheum. Dis. 16, 471\u2013480 (1957).","journal-title":"Ann. Rheum. Dis."},{"key":"1178_CR111","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/RHU.0000000000000745","volume":"24","author":"T Pecanha","year":"2018","unstructured":"Pecanha, T. et al. Chronotropic incompetence and reduced heart rate recovery in rheumatoid arthritis. J. Clin. Rheumatol. 24, 375\u2013380 (2018).","journal-title":"J. Clin. Rheumatol."},{"key":"1178_CR112","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1113\/JP272944","volume":"595","author":"AM Adlan","year":"2017","unstructured":"Adlan, A. M., Paton, J. F., Lip, G. Y., Kitas, G. D. & Fisher, J. P. Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis. J. Physiol. 595, 967\u2013981 (2017).","journal-title":"J. Physiol."},{"key":"1178_CR113","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2119\/2006-00108.Goldstein","volume":"13","author":"RS Goldstein","year":"2007","unstructured":"Goldstein, R. S. et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13, 210\u2013215 (2007).","journal-title":"Mol. Med."},{"key":"1178_CR114","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/joim.12626","volume":"282","author":"FA Koopman","year":"2017","unstructured":"Koopman, F. A., van Maanen, M. A., Vervoordeldonk, M. J. & Tak, P. P. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J. Intern. Med. 282, 64\u201375 (2017).","journal-title":"J. Intern. Med."},{"key":"1178_CR115","doi-asserted-by":"publisher","first-page":"589079","DOI":"10.3389\/fmed.2020.589079","volume":"7","author":"F Ingegnoli","year":"2020","unstructured":"Ingegnoli, F. et al. The link between autonomic nervous system and rheumatoid arthritis: from bench to bedside. Front. Med. 7, 589079 (2020).","journal-title":"Front. Med."},{"key":"1178_CR116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nrrheum.2009.31","volume":"5","author":"MA van Maanen","year":"2009","unstructured":"van Maanen, M. A., Vervoordeldonk, M. J. & Tak, P. P. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 229\u2013232 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR117","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1136\/ard.2009.118554","volume":"69","author":"MA van Maanen","year":"2010","unstructured":"van Maanen, M. A., Stoof, S. P., Larosa, G. J., Vervoordeldonk, M. J. & Tak, P. P. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor \u03b17 subunit gene knockout mice. Ann. Rheum. Dis. 69, 1717\u20131723 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1178_CR118","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13075-016-1087-x","volume":"18","author":"A Thanou","year":"2016","unstructured":"Thanou, A. et al. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Res. Ther. 18, 197 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"1178_CR119","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1046\/j.1365-2249.1997.4501466.x","volume":"110","author":"S Maule","year":"1997","unstructured":"Maule, S. et al. Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures. Clin. Exp. Immunol. 110, 423\u2013427 (1997).","journal-title":"Clin. Exp. Immunol."},{"key":"1178_CR120","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0961203306076223","volume":"16","author":"L Stojanovich","year":"2007","unstructured":"Stojanovich, L. et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sj\u00f6gren syndrome and other autoimmune diseases. Lupus 16, 181\u2013185 (2007).","journal-title":"Lupus"},{"key":"1178_CR121","doi-asserted-by":"publisher","first-page":"R1261","DOI":"10.1152\/ajpregu.00362.2017","volume":"315","author":"GS Pham","year":"2018","unstructured":"Pham, G. S., Wang, L. A. & Mathis, K. W. Pharmacological potentiation of the efferent vagus nerve attenuates blood pressure and renal injury in a murine model of systemic lupus erythematosus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 315, R1261\u2013R1271 (2018).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"1178_CR122","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13213","volume":"5","author":"AS Fairley","year":"2017","unstructured":"Fairley, A. S. & Mathis, K. W. Cholinergic agonists reduce blood pressure in a mouse model of systemic lupus erythematosus. Physiol. Rep. 5, e13213 (2017).","journal-title":"Physiol. Rep."},{"key":"1178_CR123","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1136\/annrheumdis-2020-217872","volume":"80","author":"C Aranow","year":"2021","unstructured":"Aranow, C. et al. Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial. Ann. Rheum. Dis. 80, 203\u2013208 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1178_CR124","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/nm.4422","volume":"23","author":"RM Pirzgalska","year":"2017","unstructured":"Pirzgalska, R. M. et al. Sympathetic neuron-associated macrophages contribute to obesity by importing and metabolizing norepinephrine. Nat. Med. 23, 1309\u20131318 (2017).","journal-title":"Nat. Med."},{"key":"1178_CR125","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1749-6632.2003.tb03142.x","volume":"992","author":"M Cutolo","year":"2003","unstructured":"Cutolo, M., Sulli, A., Pizzorni, C., Craviotto, C. & Straub, R. H. Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 992, 107\u2013117 (2003).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 2","key":"1178_CR126","doi-asserted-by":"publisher","first-page":"II65","DOI":"10.1007\/s003930070021","volume":"59","author":"M Cutolo","year":"2000","unstructured":"Cutolo, M. et al. The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. Z. Rheumatol. 59 (Suppl. 2), II65\u2013II69 (2000).","journal-title":"Z. Rheumatol."},{"key":"1178_CR127","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2796.2010.02218.x","volume":"267","author":"RH Straub","year":"2010","unstructured":"Straub, R. H., Cutolo, M., Buttgereit, F. & Pongratz, G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J. Intern. Med. 267, 543\u2013560 (2010).","journal-title":"J. Intern. Med."},{"key":"1178_CR128","first-page":"595","volume":"52","author":"IJ Elenkov","year":"2000","unstructured":"Elenkov, I. J., Wilder, R. L., Chrousos, G. P. & Vizi, E. S. The sympathetic nerve \u2013 an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595\u2013638 (2000).","journal-title":"Pharmacol. Rev."},{"key":"1178_CR129","first-page":"S23","volume":"29","author":"RH Straub","year":"2011","unstructured":"Straub, R. H., Buttgereit, F. & Cutolo, M. Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases - a role for misguided energy regulation. Clin. Exp. Rheumatol. 29, S23\u2013S31 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1178_CR130","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","volume":"27","author":"SC Lin","year":"2018","unstructured":"Lin, S. C. & Hardie, D. G. AMPK: sensing glucose as well as cellular energy status. Cell Metab. 27, 299\u2013313 (2018).","journal-title":"Cell Metab."},{"key":"1178_CR131","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","volume":"18","author":"GR Steinberg","year":"2019","unstructured":"Steinberg, G. R. & Carling, D. AMP-activated protein kinase: the current landscape for drug development. Nat. Rev. Drug Discov. 18, 527\u2013551 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1178_CR132","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1080\/1744666X.2021.1964957","volume":"17","author":"S Iwata","year":"2021","unstructured":"Iwata, S. & Tanaka, Y. Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus. Expert. Rev. Clin. Immunol. 17, 1121\u20131130 (2021).","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"1178_CR133","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41584-019-0192-z","volume":"15","author":"J McHugh","year":"2019","unstructured":"McHugh, J. AMPK: a therapeutic target in RA? Nat. Rev. Rheumatol. 15, 188 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR134","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/BOR.0000000000000594","volume":"31","author":"E Liu","year":"2019","unstructured":"Liu, E. & Perl, A. Pathogenesis and treatment of autoimmune rheumatic diseases. Curr. Opin. Rheumatol. 31, 307\u2013315 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1178_CR135","doi-asserted-by":"publisher","first-page":"696602","DOI":"10.3389\/fcell.2021.696602","volume":"9","author":"D Yi","year":"2021","unstructured":"Yi, D. et al. AMPK signaling in energy control, cartilage biology, and osteoarthritis. Front. Cell Dev. Biol. 9, 696602 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1178_CR136","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrrheum.2016.65","volume":"12","author":"RF Loeser","year":"2016","unstructured":"Loeser, R. F., Collins, J. A. & Diekman, B. O. Ageing and the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 12, 412\u2013420 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR137","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrrheum.2014.162","volume":"11","author":"R Liu-Bryan","year":"2015","unstructured":"Liu-Bryan, R. & Terkeltaub, R. Emerging regulators of the inflammatory process in osteoarthritis. Nat. Rev. Rheumatol. 11, 35\u201344 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR138","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.3390\/ijms22137231","volume":"22","author":"J Kim","year":"2021","unstructured":"Kim, J., Kim, Y. S. & Park, S. H. Metformin as a treatment strategy for Sj\u00f6gren\u2019s syndrome. Int. J. Mol. Sci. 22, 7231 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1178_CR139","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41590-018-0296-7","volume":"20","author":"Z Wen","year":"2019","unstructured":"Wen, Z. et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat. Immunol. 20, 313\u2013325 (2019).","journal-title":"Nat. Immunol."},{"key":"1178_CR140","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phrs.2017.10.001","volume":"128","author":"C Speirs","year":"2018","unstructured":"Speirs, C., Williams, J. J. L., Riches, K., Salt, I. P. & Palmer, T. M. Linking energy sensing to suppression of JAK-STAT signalling: a potential route for repurposing AMPK activators? Pharmacol. Res. 128, 88\u2013100 (2018).","journal-title":"Pharmacol. Res."},{"key":"1178_CR141","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.molimm.2021.10.007","volume":"140","author":"W Cai","year":"2021","unstructured":"Cai, W. et al. The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner. Mol. Immunol. 140, 186\u2013195 (2021).","journal-title":"Mol. Immunol."},{"key":"1178_CR142","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/ph13090234","volume":"13","author":"T Salvatore","year":"2020","unstructured":"Salvatore, T. et al. Metformin: a potential therapeutic tool for rheumatologists. Pharmaceuticals 13, 234 (2020).","journal-title":"Pharmaceuticals"},{"key":"1178_CR143","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/annrheumdis-2014-206305","volume":"75","author":"CC Thornton","year":"2016","unstructured":"Thornton, C. C. et al. Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation. Ann. Rheum. Dis. 75, 439\u2013448 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1178_CR144","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1172\/JCI31516","volume":"117","author":"M Claret","year":"2007","unstructured":"Claret, M. et al. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J. Clin. Invest. 117, 2325\u20132336 (2007).","journal-title":"J. Clin. Invest."},{"key":"1178_CR145","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.celrep.2017.11.102","volume":"22","author":"S Okamoto","year":"2018","unstructured":"Okamoto, S. et al. Activation of AMPK-regulated CRH neurons in the PVH is sufficient and necessary to induce dietary preference for carbohydrate over fat. Cell Rep. 22, 706\u2013721 (2018).","journal-title":"Cell Rep."},{"key":"1178_CR146","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.cmet.2008.03.006","volume":"7","author":"M L\u00f3pez","year":"2008","unstructured":"L\u00f3pez, M. et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 7, 389\u2013399 (2008).","journal-title":"Cell Metab."},{"key":"1178_CR147","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1128\/MCB.01914-08","volume":"29","author":"B Xue","year":"2009","unstructured":"Xue, B. et al. Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues. Mol. Cell Biol. 29, 4563\u20134573 (2009).","journal-title":"Mol. Cell Biol."},{"key":"1178_CR148","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cmet.2017.06.014","volume":"26","author":"N Martinez-Sanchez","year":"2017","unstructured":"Martinez-Sanchez, N. et al. Hypothalamic AMPK-ER stress-JNK1 axis mediates the central actions of thyroid hormones on energy balance. Cell Metab. 26, 212\u2013229.e2 (2017).","journal-title":"Cell Metab."},{"key":"1178_CR149","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2337\/diabetes.53.8.1953","volume":"53","author":"RJ McCrimmon","year":"2004","unstructured":"McCrimmon, R. J. et al. Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 53, 1953\u20131958 (2004).","journal-title":"Diabetes"},{"key":"1178_CR150","doi-asserted-by":"publisher","first-page":"444","DOI":"10.2337\/db07-0837","volume":"57","author":"RJ McCrimmon","year":"2008","unstructured":"McCrimmon, R. J. et al. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. Diabetes 57, 444\u2013450 (2008).","journal-title":"Diabetes"},{"key":"1178_CR151","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2337\/db17-1538","volume":"67","author":"P Seoane-Collazo","year":"2018","unstructured":"Seoane-Collazo, P. et al. SF1-specific AMPK\u03b11 deletion protects against diet-induced obesity. Diabetes 67, 2213\u20132226 (2018).","journal-title":"Diabetes"},{"key":"1178_CR152","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2337\/db11-1079","volume":"61","author":"PB Mart\u00ednez de Morentin","year":"2012","unstructured":"Mart\u00ednez de Morentin, P. B. et al. Nicotine induces negative energy balance through hypothalamic AMP-activated protein kinase. Diabetes 61, 807\u2013817 (2012).","journal-title":"Diabetes"},{"key":"1178_CR153","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.2337\/db14-0302","volume":"63","author":"D Beiroa","year":"2014","unstructured":"Beiroa, D. et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 63, 3346\u20133358 (2014).","journal-title":"Diabetes"},{"key":"1178_CR154","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.celrep.2016.07.045","volume":"16","author":"L Martins","year":"2016","unstructured":"Martins, L. et al. A functional link between AMPK and orexin mediates the effect of BMP8B on energy balance. Cell Rep. 16, 2231\u20132242 (2016).","journal-title":"Cell Rep."},{"key":"1178_CR155","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1530\/JOE-16-0425","volume":"232","author":"N Martinez-Sanchez","year":"2017","unstructured":"Martinez-Sanchez, N. et al. Thyroid hormones induce browning of white fat. J. Endocrinol. 232, 351\u2013362 (2017).","journal-title":"J. Endocrinol."},{"key":"1178_CR156","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2014.03.031","volume":"20","author":"PB Martinez de Morentin","year":"2014","unstructured":"Martinez de Morentin, P. B. et al. Estradiol regulates brown adipose tissue thermogenesis via hypothalamic AMPK. Cell Metab. 20, 41\u201353 (2014).","journal-title":"Cell Metab."},{"key":"1178_CR157","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nm.2207","volume":"16","author":"M Lopez","year":"2010","unstructured":"Lopez, M. et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med. 16, 1001\u20131008 (2010).","journal-title":"Nat. Med."},{"key":"1178_CR158","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2012.02.066","volume":"149","author":"AJ Whittle","year":"2012","unstructured":"Whittle, A. J. et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149, 871\u2013885 (2012).","journal-title":"Cell"},{"key":"1178_CR159","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s42255-021-00467-8","volume":"3","author":"E Milbank","year":"2021","unstructured":"Milbank, E. et al. Small extracellular vesicle-mediated targeting of hypothalamic AMPK\u03b11 corrects obesity through BAT activation. Nat. Metab. 3, 1415\u20131431 (2021).","journal-title":"Nat. Metab."},{"key":"1178_CR160","doi-asserted-by":"publisher","first-page":"155350","DOI":"10.1016\/j.metabol.2022.155350","volume":"139","author":"E Milbank","year":"2023","unstructured":"Milbank, E. et al. Small extracellular vesicle targeting of hypothalamic AMPK\u03b11 promotes weight loss in leptin receptor deficient mice. Metabolism 139, 155350 (2023).","journal-title":"Metabolism"},{"key":"1178_CR161","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/JIR.S16508","volume":"4","author":"K Binymin","year":"2011","unstructured":"Binymin, K., Herrick, A., Carlson, G. & Hopkins, S. The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis. J. Inflamm. Res. 4, 61\u201366 (2011).","journal-title":"J. Inflamm. Res."},{"key":"1178_CR162","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3904\/kjim.2014.29.4.516","volume":"29","author":"JY Choe","year":"2014","unstructured":"Choe, J. Y., Park, S. H., Lee, H., Kwon, H. H. & Kim, S. K. Resting energy expenditure is not associated with disease activity in women with rheumatoid arthritis: cross-sectional study. Korean J. Intern. Med. 29, 516\u2013524 (2014).","journal-title":"Korean J. Intern. Med."},{"key":"1178_CR163","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/BF01121584","volume":"1","author":"SL Brooks","year":"1981","unstructured":"Brooks, S. L., Neville, A. M., Rothwell, N. J., Stock, M. J. & Wilson, S. Sympathetic activation of brown-adipose-tissue thermogenesis in cachexia. Biosci. Rep. 1, 509\u2013517 (1981).","journal-title":"Biosci. Rep."},{"key":"1178_CR164","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/BF00402783","volume":"111","author":"FG Shellock","year":"1986","unstructured":"Shellock, F. G., Riedinger, M. S. & Fishbein, M. C. Brown adipose tissue in cancer patients: possible cause of cancer-induced cachexia. J. Cancer Res. Clin. Oncol. 111, 82\u201385 (1986).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1178_CR165","first-page":"2405","volume":"60","author":"C Bing","year":"2000","unstructured":"Bing, C. et al. Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia. Cancer Res. 60, 2405\u20132410 (2000).","journal-title":"Cancer Res."},{"key":"1178_CR166","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1158\/0008-5472.CAN-11-3536","volume":"72","author":"M Tsoli","year":"2012","unstructured":"Tsoli, M. et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer Res. 72, 4372\u20134382 (2012).","journal-title":"Cancer Res."},{"key":"1178_CR167","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli, M. et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 20, 433\u2013447 (2014).","journal-title":"Cell Metab."},{"key":"1178_CR168","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/cne.10643","volume":"460","author":"G Cano","year":"2003","unstructured":"Cano, G. et al. Anatomical substrates for the central control of sympathetic outflow to interscapular adipose tissue during cold exposure. J. Comp. Neurol. 460, 303\u2013326 (2003).","journal-title":"J. Comp. Neurol."},{"key":"1178_CR169","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.cmet.2014.02.007","volume":"19","author":"SF Morrison","year":"2014","unstructured":"Morrison, S. F., Madden, C. J. & Tupone, D. Central neural regulation of brown adipose tissue thermogenesis and energy expenditure. Cell Metab. 19, 741\u2013756 (2014).","journal-title":"Cell Metab."},{"key":"1178_CR170","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41584-020-0370-z","volume":"16","author":"F Buttgereit","year":"2020","unstructured":"Buttgereit, F. Views on glucocorticoid therapy in rheumatology: the age of convergence. Nat. Rev. Rheumatol. 16, 239\u2013246 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR171","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41584-020-0371-y","volume":"16","author":"RS Hardy","year":"2020","unstructured":"Hardy, R. S., Raza, K. & Cooper, M. S. Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases. Nat. Rev. Rheumatol. 16, 133\u2013144 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR172","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/ard.8.2.97","volume":"8","author":"PS Hench","year":"1949","unstructured":"Hench, P. S., Kendall, E. C., Slocumb, C. H. & Polley, H. F. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocortical hormone in arthritis: preliminary report. Ann. Rheum. Dis. 8, 97\u2013104 (1949).","journal-title":"Ann. Rheum. Dis."},{"key":"1178_CR173","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/164_2015_1","volume":"233","author":"L Magomedova","year":"2016","unstructured":"Magomedova, L. & Cummins, C. L. Glucocorticoids and metabolic control. Handb. Exp. Pharmacol. 233, 73\u201393 (2016).","journal-title":"Handb. Exp. Pharmacol."},{"key":"1178_CR174","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41584-021-00593-3","volume":"17","author":"F Atzeni","year":"2021","unstructured":"Atzeni, F. et al. Cardiovascular effects of approved drugs for rheumatoid arthritis. Nat. Rev. Rheumatol. 17, 270\u2013290 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR175","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein, B. N. & Aune, T. M. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat. Rev. Rheumatol. 16, 145\u2013154 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1178_CR176","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz, M., Guigas, B., Bertrand, L., Pollak, M. & Viollet, B. Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953\u2013966 (2014).","journal-title":"Cell Metab."},{"key":"1178_CR177","doi-asserted-by":"publisher","first-page":"102697","DOI":"10.1016\/j.ebiom.2020.102697","volume":"53","author":"J Latorre","year":"2020","unstructured":"Latorre, J. et al. Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes. EBioMedicine 53, 102697 (2020).","journal-title":"EBioMedicine"},{"key":"1178_CR178","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","volume":"16","author":"KY Kang","year":"2013","unstructured":"Kang, K. Y. et al. Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis. Int. Immunopharmacol. 16, 85\u201392 (2013).","journal-title":"Int. Immunopharmacol."},{"key":"1178_CR179","doi-asserted-by":"publisher","first-page":"973986","DOI":"10.1155\/2014\/973986","volume":"2014","author":"HJ Son","year":"2014","unstructured":"Son, H. J. et al. Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17\/Treg balance and osteoclastogenesis. Mediators Inflamm. 2014, 973986 (2014).","journal-title":"Mediators Inflamm."},{"key":"1178_CR180","doi-asserted-by":"publisher","first-page":"E210","DOI":"10.1016\/S2665-9913(20)30004-7","volume":"2","author":"F Sun","year":"2020","unstructured":"Sun, F. et al. Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Rheumatol. 2, E210\u2013E216 (2020).","journal-title":"Lancet Rheumatol."},{"key":"1178_CR181","doi-asserted-by":"publisher","first-page":"107575","DOI":"10.1016\/j.intimp.2021.107575","volume":"95","author":"MS Abdallah","year":"2021","unstructured":"Abdallah, M. S. et al. The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: a proof-of-concept, randomized, double-blind, placebo-controlled trial. Int. Immunopharmacol. 95, 107575 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"1178_CR182","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/annrheumdis-2019-216713","volume":"79","author":"J Li","year":"2020","unstructured":"Li, J. et al. Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann. Rheum. Dis. 79, 635\u2013645 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1178_CR183","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.3389\/fphar.2020.01114","volume":"11","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Metformin mitigates cartilage degradation by activating AMPK\/SIRT1-mediated autophagy in a mouse osteoarthritis model. Front. Pharmacol. 11, 1114 (2020).","journal-title":"Front. Pharmacol."},{"key":"1178_CR184","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191242","volume":"13","author":"CH Lu","year":"2018","unstructured":"Lu, C. H. et al. Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: a nationwide, retrospective, matched-cohort study in Taiwan. PLoS ONE 13, e0191242 (2018).","journal-title":"PLoS ONE"},{"key":"1178_CR185","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13075-019-1904-0","volume":"21","author":"JW Kim","year":"2019","unstructured":"Kim, J. W. et al. Metformin improves salivary gland inflammation and hypofunction in murine Sj\u00f6gren\u2019s syndrome. Arthritis Res. Ther. 21, 136 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"1178_CR186","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41568-020-00299-w","volume":"20","author":"A Moller","year":"2020","unstructured":"Moller, A. & Lobb, R. J. The evolving translational potential of small extracellular vesicles in cancer. Nat. Rev. Cancer 20, 697\u2013709 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"1178_CR187","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213\u2013228 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1178_CR188","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41574-022-00666-7","volume":"18","author":"N Jafari","year":"2022","unstructured":"Jafari, N., Llevenes, P. & Denis, G. V. Exosomes as novel biomarkers in metabolic disease and obesity-related cancers. Nat. Rev. Endocrinol. 18, 327\u2013328 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1178_CR189","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"1178_CR190","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel, D. M. & Gould, S. J. Exosomes. Annu. Rev. Biochem. 88, 487\u2013514 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"1178_CR191","doi-asserted-by":"publisher","first-page":"815456","DOI":"10.3389\/fnut.2021.815456","volume":"8","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee, S. et al. Understanding the effects of antipsychotics on appetite control. Front. Nutr. 8, 815456 (2021).","journal-title":"Front. Nutr."},{"key":"1178_CR192","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.molmet.2016.01.008","volume":"5","author":"M Alvarez-Crespo","year":"2016","unstructured":"Alvarez-Crespo, M. et al. Essential role of UCP1 modulating the central effects of thyroid hormones on energy balance. Mol. Metab. 5, 271\u2013282 (2016).","journal-title":"Mol. Metab."},{"key":"1178_CR193","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056660","volume":"8","author":"M Tanida","year":"2013","unstructured":"Tanida, M., Yamamoto, N., Shibamoto, T. & Rahmouni, K. Involvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation. PLoS ONE 8, e56660 (2013).","journal-title":"PLoS ONE"},{"key":"1178_CR194","doi-asserted-by":"publisher","first-page":"101465","DOI":"10.1016\/j.molmet.2022.101465","volume":"59","author":"E Rial-Pensado","year":"2022","unstructured":"Rial-Pensado, E. et al. Obesity induces resistance to central action of BMP8B through a mechanism involving the BBSome. Mol. Metab. 59, 101465 (2022).","journal-title":"Mol. Metab."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01178-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T14:04:12Z","timestamp":1732197852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-024-01178-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":194,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1038\/s41584-024-01178-6","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"30 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.L. declares that he holds an International Patent Application entitled <i>\u201c<\/i>Populations of small extracellular vesicles for use in the treatment of obesity<i>\u201d<\/i>, PCT\/EP2022\/071463. O.G. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}